## CBRE: CBRE Group, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($154.61)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. News | Here are CoStar's top office stories of 2025**
- Source: CoStar | 20260102T183942 | Somewhat-Bullish | Relevance: 70%
- The year 2025 saw a significant rebound in the office sector as companies across tech, legal, and finance sectors implemented stricter in-person office mandates, leading to a spike in leasing activity. This shift, combined with some office owners converting empty buildings for other uses, boosted demand and marked 2025 as a pivotal year for the office real estate market. Key stories include increased office space removal, major tower teardown considerations, federal lease cuts, and significant corporate relocations.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Keefe, Bruyette | $185 | $168 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Keefe, Bruyette | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($1.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 16.0% (-0.2%)
- Blackrock Inc.: 9.3% (-1.2%)
- State Street Corpora: 4.7% (+0.8%)
- Principal Financial : 3.2% (+9.3%)
- FMR, LLC: 2.8% (+89.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.82 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +10%). Insider selling cluster ($1.5M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.7B |
| Beta | 1.34 |
| 52W Range | $108.45 - $171.00 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.82 |
| Forward P/E | 21.8 |
| Current P/E | 25.3 |
| YoY Growth | 16.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.3% to -1.0% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.10x) but short-term weakness (below SMA20). RSI neutral at 49. OFD pattern: -DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.97% (CS: 22) | Neutral |
| RSI_14 | 49.1 | Neutral |
| MACD Histogram | -0.23 | Bearish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 1.014x | Above |
| vs SMA200 | 1.099x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $160.19
- **Stop Loss:** $154.61 (3.5% risk)
- **Target:** $165.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 258
- **Position Value:** $41,329.02
- **Portfolio %:** 41.33%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-12 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.46 | $1.61 | +10.6% |
| 2025Q2 | $1.07 | $1.19 | +11.2% |
| 2025Q1 | $0.76 | $0.86 | +12.7% |
| 2024Q4 | $2.23 | $2.32 | +3.9% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*